Previous studies have reported that BCL9L can promote the occurrence and development of choriocarcinoma (Matsuura et al., 2011), breast cancer (Toya et al., 2007), colon cancer (Deka et al., 2010), and pancreatic cancer (Hallas et al., 2016). Here, BCL9L is linked to familial pancreatic carcinoma.